secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-08-03T21:22:39+00:00
Accession:  0001493152-26-035861
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS completes interference study; on track for 510(k) submission in H2 2026
----------------------------------------------------------------------------

- Completed Interference Study for fingerprint drug screening system, testing common substances (hand creams, alcohol, oils, dirt, water) for impact on codeine detection.
- Study conducted with CenExel Clinical Research, following FDA guidance and ICH GCP guidelines; data analysis underway with LC-MS/MS verification.
- Company remains on track to submit FDA 510(k) package in calendar H2 2026 for U.S. market clearance for opiate codeine detection.
- Part of comprehensive program including Cut-off Study, Method Comparison Study, precision and penetration testing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226035861/0001493152-26-035861-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226035861/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035861

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer